Clinical Trials Directory

Trials / Unknown

UnknownNCT02836327

Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

Multimodel MRI to Explore the Pathophysiology of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Chinese PLA General Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

To investigate multimodel MRI exploring the pathophysiology of multiple sclerosis and neuromyelitis optica spectrum disorders. The investigators use multimodel MRI to evaluate the extent of blood-brain barrier and white matter fiber tracts destruction , iron deposition and cerebral blood flow of associated regions in multiple sclerosis and neuromyelitis optica spectrum disorders using contrast-enhanced magnetic resonance imaging , quantitative susceptibility mapping, diffusion tension imaging, and arterial spin labeling with post labeling delay of 2.0 seconds. Transfer constant volume , magnetic susceptibility, cerebral blood flow and fractional anisotropy(FA) value were measured in lesion and normal appearing white matter.

Detailed description

Patients: Patients with multiple sclerosis and neuromyelitis optica spectrum disorders were included. clinical characteristics such as disease duration, expanded disability status scale(EDSS) score, age, associated laboratory examination(autoantibodies directed to aquaporin-4 and oligoclonal bands in serum as well as cerebrospinal fluid)were recorded. Imaging scan were conducted at admission, six months and one year after admission Imaging protocols: MRI scan protocols: T2 weighted image, T1 weighted image, Diffusion weighted image(DWI), fluid-attenuated inversion recovery(FLAIR), dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI) , diffusion tension imaging(DTI) ,quantitative susceptibility mapping(QSM) , arterial spin labeling(ASL) with post labeling delay(PLD) of seconds, sagittal CUBE Fluid Attenuation Inversion Recovery (FLAIR) images, sagittal 3-dimensional Fast Spoiled Gradient Echo(3D-FSPGR). Contrast agent: Omniscan 0.1mmol/kg, Inject rate:2ml/s Imaging evaluation: Transfer constant volume value measured by DCE-MRI indicates the extent of blood-brain barrier destruction. Magnetic susceptibility manifests iron deposition in lesions and normal appearing white matter. Diffusion tension imaging demonstrates the extent of white matter fiber tracts destruction. Arterial spin labeling(ASL) with post labeling delay(PLD)of seconds shows cerebral blood flow in associated regions.

Conditions

Interventions

TypeNameDescription
OTHERMagnetic Resonance ImagingMagnetic Resonance Imaging

Timeline

Start date
2014-09-01
Primary completion
2019-09-01
Completion
2021-09-01
First posted
2016-07-19
Last updated
2016-08-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02836327. Inclusion in this directory is not an endorsement.

Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders (NCT02836327) · Clinical Trials Directory